The Human Research Protection Program (HRPP) reviews and monitors research involving human subjects at UCSF and several affiliate institutions to ensure the welfare, safety, privacy, and ethical treatment of participants in human research studies. Read more about the HRPP program.
The HRPP is comprised of 3 groups:
- Institutional Review Board (IRB), which reviews human subject research studies — learn how to submit to the IRB.
- Quality Improvement Unit (QIU), which conducts monitoring, education and other QI activities.
- Human Gamete, Embryo and Stem Cell Research (GESCR) Committee.
IRB and COVID-19
Please read our FAQs, they will be continually updated in response to questions that arise.
- The IRB office, committee, and iRIS systems are fully operational.
- IRB Meetings are taking place remotely, on their normal schedule.
- We have established dedicated IRB analysts for COVID research. Our focus is to accelerate and facilitate COVID Research and to ensure all studies proceed per University policy.
News
- IRB Spotlight: Jennifer Michlitsch, MD (8/15/24)
- Updated IRB Review Fees Effective July 1, 2024 (6/25/24)
- IRB Spotlight: Alan Venook, MD (5/17/24)
- Changes to April 17th bulletin (5/7/24)
- New Study Site Changes Form & Updated Modification Form (4/17/24)
- Guidance Updates: Reporting Adverse Events, Protocol Violations, and Investigator’s Brochures to the UCSF IRB (4/1/24)
- IRB Spotlight: Victor Reus, MD (3/15/24)
- IRB Spotlight: Gordon Fung, MD, MPH (1/16/24)